Showing results (1-10 of 2,482) with videos related to
Sort By:
Pageof 249
Anesthesia and Analgesia|October 1, 1982
Emergency percutaneous transtracheal ventilation during anesthesia using readily available equipmentP E Scuderi, C H McLeskey, P B ComerJAMA|July 11, 1980
Avoidance of surgical hyperglycemia in diabetic patientsR E Woodruff, S B Lewis, C H McLeskey, et al.Journal of Clinical Anesthesia|April 25, 2000
Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study GroupB K Philip, C H McLeskey, J E Chelly, et al.Anesthesia and Analgesia|October 1, 1993
The initial clinical experience of 1819 physicians in maintaining anesthesia with propofol: characteristics associated with prolonged time to awakeningJ L Apfelbaum, T H Grasela, C C Hug, et al.Anesthesia and Analgesia|October 1, 1993
Adverse events in a multicenter phase IV study of propofol: evaluation by anesthesiologists and postanesthesia care unit nursesC H McLeskey, C A Walawander, M L Nahrwold, et al.Anesthesia and Analgesia|October 1, 1993
The role of pharmacoepidemiology research in postmarketing surveillance and anesthesia practice/critical care medicineT H Grasela, W D Watkins, C C Hug, et al.Anesthesia and Analgesia|October 1, 1993
Effects on recovery when isoflurane is used to supplement propofol-nitrous oxide anesthesiaP F White, T H Stanley, J L Apfelbaum, et al.Anesthesia and Analgesia|October 1, 1993
Hemodynamic effects of propofol: data from over 25,000 patientsC C Hug, C H McLeskey, M L Nahrwold, et al.Anesthesia and Analgesia|October 1, 1993
How do anesthesiologists select patients when introducing a new drug into practice?M F Roizen, T H Stanley, R A Thisted, et al.Anesthesia and Analgesia|October 1, 1993
Phase IV study of propofol: validation of the data setM L Nahrwold, M F Roizen, T H Stanley, et al.Pageof 249